← Eichor
Study identifier: NCT06096246 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

Condition: Persistent Atrial Fibrillation · Cardiac Arrhythmia · Catheter Ablation  ·  Sponsor: Barts & The London NHS Trust

PhaseNA
Planned participants208
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.

This description comes directly from the study's public registry record.

Talk to the study team

Malcolm Finlay, FRCP PhD  ·  02037658635  ·  malcolm.finlay1@nhs.net

Vijayabharathy Kanthasamy, MRCP  ·  02037658635  ·  vijayabharathy.kanthasamy@nhs.net

Always discuss trial participation with your own doctor first.

Locations (1)

Barts Heart CentreLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06096246